LAZARD ASSET MANAGEMENT LLC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2022$4,620
-100.0%
8,400,000
-50.9%
0.01%
-57.1%
Q3 2022$9,629,000
+1.7%
17,100,0000.0%0.01%
+7.7%
Q2 2022$9,469,000
-3.8%
17,100,000
-10.5%
0.01%
+18.2%
Q1 2022$9,848,000
-23.2%
19,100,000
-21.4%
0.01%
-21.4%
Q4 2021$12,818,00024,300,0000.01%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2023
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 29,679,000$23,720,0007.42%
SILVERBACK ASSET MANAGEMENT LLC 11,750,000$6,487,1750.92%
DCF Advisers, LLC 1,550,000$884,0000.57%
Context Capital Management, LLC 14,764$8,274,0000.56%
AGF Investments LLC 7,000,000$3,872,0000.36%
WHITEBOX ADVISORS LLC 19,600,000$10,682,0000.30%
Pentwater Capital Management LP 46,411,000$26,134,0000.29%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$11,591,0000.27%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 24,000,000$13,275,0000.24%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 14,900,000$8,493,0000.12%
View complete list of ESPERION THERAPEUTICS INC NE shareholders